We will be at bio 2026 June, san diego! cONNECT WITH US!

Two antique world maps showing continents and oceans.

About Us

We didn’t step down from the corporate world to consult, we stepped up as founders to build alongside you.
We built this firm because we have navigated the exact same hurdles you are facing today: the lack of early funding, the opaque barriers to entering the US ecosystem, and the steep learning curve of aligning with American investors.

We understand the early-stage journey intimately. Whether your life science venture is bootstrapped, relying on non-dilutive grants, or actively raising a Pre-Seed or Series A round, we know the cash constraints and critical pivot points you manage daily.

Because every regional startup ecosystem operates by its own rules, crossing borders requires more than just a good pitch deck. It requires the right mindset. We bring a founder-first approach to cross-border strategy, leveraging our deep network of family offices, venture capitalists, accelerators, and incubators. Our focus is entirely on helping global innovators decode the US market, refine their strategy, and establish themselves with the right players to scale their science.

Our mission

Our mission is to equip early-stage biotech and life science founders with the strategic roadmap and cross-border insights required to successfully penetrate the US market. Recognizing that every entrepreneurial ecosystem is fundamentally different, we provide tailored, founder-centric support to help you navigate complex market entries, secure the right capital, and align your vision with the investors and partners who can accelerate your growth.

Our vision

Our vision is to drive the next wave of global life science innovation while actively boosting the American entrepreneurial economy. By serving as the definitive bridge for top-tier international talent and founders, we aim to integrate breakthrough global science into the US ecosystem, foster robust cross-border collaboration, and seamlessly expand transformative biotech ventures into new, high-value markets.

Celesticus© 2026. All rights reserved.